TLX250-CDx (Zircaix®) Included in Leading International Guidelines for Renal Imaging
- Written by PR Newswire
![]() |
MELBOURNE, Australia and INDIANAPOLIS, Oct. 23, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today welcomes updated guidelines from the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Association of Nuclear Medicine (EANM) and The American College of Nuclear Medicine (ACNM) that,...
Read more: TLX250-CDx (Zircaix®) Included in Leading International Guidelines for Renal Imaging















